231 related articles for article (PubMed ID: 19515851)
21. Pathological mechanisms underlying TDP-43 driven neurodegeneration in FTLD-ALS spectrum disorders.
Janssens J; Van Broeckhoven C
Hum Mol Genet; 2013 Oct; 22(R1):R77-87. PubMed ID: 23900071
[TBL] [Abstract][Full Text] [Related]
22. The ALS disease-associated mutant TDP-43 impairs mitochondrial dynamics and function in motor neurons.
Wang W; Li L; Lin WL; Dickson DW; Petrucelli L; Zhang T; Wang X
Hum Mol Genet; 2013 Dec; 22(23):4706-19. PubMed ID: 23827948
[TBL] [Abstract][Full Text] [Related]
23. Neurodegeneration-associated protein fragments as short-lived substrates of the N-end rule pathway.
Brower CS; Piatkov KI; Varshavsky A
Mol Cell; 2013 Apr; 50(2):161-71. PubMed ID: 23499006
[TBL] [Abstract][Full Text] [Related]
24. The truncated C-terminal RNA recognition motif of TDP-43 protein plays a key role in forming proteinaceous aggregates.
Wang YT; Kuo PH; Chiang CH; Liang JR; Chen YR; Wang S; Shen JC; Yuan HS
J Biol Chem; 2013 Mar; 288(13):9049-57. PubMed ID: 23372158
[TBL] [Abstract][Full Text] [Related]
25. Conserved acidic amino acid residues in a second RNA recognition motif regulate assembly and function of TDP-43.
Shodai A; Ido A; Fujiwara N; Ayaki T; Morimura T; Oono M; Uchida T; Takahashi R; Ito H; Urushitani M
PLoS One; 2012; 7(12):e52776. PubMed ID: 23300771
[TBL] [Abstract][Full Text] [Related]
26. TARDBP mutation analysis in TDP-43 proteinopathies and deciphering the toxicity of mutant TDP-43.
Gendron TF; Rademakers R; Petrucelli L
J Alzheimers Dis; 2013; 33 Suppl 1(Suppl 1):S35-45. PubMed ID: 22751173
[TBL] [Abstract][Full Text] [Related]
27. Neurotoxic effects of TDP-43 overexpression in C. elegans.
Ash PE; Zhang YJ; Roberts CM; Saldi T; Hutter H; Buratti E; Petrucelli L; Link CD
Hum Mol Genet; 2010 Aug; 19(16):3206-18. PubMed ID: 20530643
[TBL] [Abstract][Full Text] [Related]
28. Cytoplasmic mislocalization of TDP-43 is toxic to neurons and enhanced by a mutation associated with familial amyotrophic lateral sclerosis.
Barmada SJ; Skibinski G; Korb E; Rao EJ; Wu JY; Finkbeiner S
J Neurosci; 2010 Jan; 30(2):639-49. PubMed ID: 20071528
[TBL] [Abstract][Full Text] [Related]
29. Gain and loss of function of ALS-related mutations of TARDBP (TDP-43) cause motor deficits in vivo.
Kabashi E; Lin L; Tradewell ML; Dion PA; Bercier V; Bourgouin P; Rochefort D; Bel Hadj S; Durham HD; Vande Velde C; Rouleau GA; Drapeau P
Hum Mol Genet; 2010 Feb; 19(4):671-83. PubMed ID: 19959528
[TBL] [Abstract][Full Text] [Related]
30. Mutations in TDP-43 link glycine-rich domain functions to amyotrophic lateral sclerosis.
Pesiridis GS; Lee VM; Trojanowski JQ
Hum Mol Genet; 2009 Oct; 18(R2):R156-62. PubMed ID: 19808791
[TBL] [Abstract][Full Text] [Related]
31. Delineation of the core aggregation sequences of TDP-43 C-terminal fragment.
Saini A; Chauhan VS
Chembiochem; 2011 Nov; 12(16):2495-501. PubMed ID: 21905193
[TBL] [Abstract][Full Text] [Related]
32. Cytoplasmic TDP-43 De-mixing Independent of Stress Granules Drives Inhibition of Nuclear Import, Loss of Nuclear TDP-43, and Cell Death.
Gasset-Rosa F; Lu S; Yu H; Chen C; Melamed Z; Guo L; Shorter J; Da Cruz S; Cleveland DW
Neuron; 2019 Apr; 102(2):339-357.e7. PubMed ID: 30853299
[TBL] [Abstract][Full Text] [Related]
33. Proteostatic imbalance and protein spreading in amyotrophic lateral sclerosis.
Cicardi ME; Marrone L; Azzouz M; Trotti D
EMBO J; 2021 May; 40(10):e106389. PubMed ID: 33792056
[TBL] [Abstract][Full Text] [Related]
34. Stress Granule Assembly Can Facilitate but Is Not Required for TDP-43 Cytoplasmic Aggregation.
Fernandes N; Nero L; Lyons SM; Ivanov P; Mittelmeier TM; Bolger TA; Buchan JR
Biomolecules; 2020 Sep; 10(10):. PubMed ID: 32992901
[TBL] [Abstract][Full Text] [Related]
35. The Pathobiology of TDP-43 C-Terminal Fragments in ALS and FTLD.
Berning BA; Walker AK
Front Neurosci; 2019; 13():335. PubMed ID: 31031584
[TBL] [Abstract][Full Text] [Related]
36. Molecular Mechanisms of TDP-43 Misfolding and Pathology in Amyotrophic Lateral Sclerosis.
Prasad A; Bharathi V; Sivalingam V; Girdhar A; Patel BK
Front Mol Neurosci; 2019; 12():25. PubMed ID: 30837838
[TBL] [Abstract][Full Text] [Related]
37. Detection of TAR DNA-binding protein 43 (TDP-43) oligomers as initial intermediate species during aggregate formation.
French RL; Grese ZR; Aligireddy H; Dhavale DD; Reeb AN; Kedia N; Kotzbauer PT; Bieschke J; Ayala YM
J Biol Chem; 2019 Apr; 294(17):6696-6709. PubMed ID: 30824544
[TBL] [Abstract][Full Text] [Related]
38. The N Termini of TAR DNA-Binding Protein 43 (TDP43) C-Terminal Fragments Influence Degradation, Aggregation Propensity, and Morphology.
Kasu YAT; Alemu S; Lamari A; Loew N; Brower CS
Mol Cell Biol; 2018 Oct; 38(19):. PubMed ID: 29987190
[TBL] [Abstract][Full Text] [Related]
39. Phosphorylation of TAR DNA-binding Protein of 43 kDa (TDP-43) by Truncated Casein Kinase 1δ Triggers Mislocalization and Accumulation of TDP-43.
Nonaka T; Suzuki G; Tanaka Y; Kametani F; Hirai S; Okado H; Miyashita T; Saitoe M; Akiyama H; Masai H; Hasegawa M
J Biol Chem; 2016 Mar; 291(11):5473-5483. PubMed ID: 26769969
[TBL] [Abstract][Full Text] [Related]
40. Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis.
Ling SC; Polymenidou M; Cleveland DW
Neuron; 2013 Aug; 79(3):416-38. PubMed ID: 23931993
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
